Gender and risk of autoimmune diseases: Possible role of estrogenic compounds

Environmental Health Perspectives

Volumn 107, Issue SUPPL. 5, 1999, Pages 681-686

  Ahmed, S Ansar ^a   Hissong, B D ^a   Verthelyi, D ^a   Donner, K ^a   Becker, K ^a   Karpuzoglu Sahin, E ^a  

^a CENTER FOR MOLECULAR MEDICINE AND INFECTIOUS DISEASES   (United States)

Author keywords

Autoantibodies; Autoimmune diseases; Autoreactive cells; B cells; Diethylstilbestrol; Endocrine disrupting chemicals; Estrogens; T cells

Indexed keywords

AUTOANTIBODY; ENVIRONMENTAL CHEMICAL; ESTROGEN; PLACEBO;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE PREDISPOSITION; ENVIRONMENTAL EXPOSURE; FEMALE; GENDER; HUMAN; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE COUNT; LYMPHOCYTE PROLIFERATION; MALE; NONHUMAN; PATHOLOGY; PRIORITY JOURNAL; SPLEEN LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION;

ANIMALIA;

EID: 0010830725     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.99107s5681     Document Type: Conference Paper

References (60)

1. Ansar Ahmed S, Penhale WJ, Talal N. Sex hormones, immune responses and autoimmune responses: mechanisms of sex hormone action. Am J Pathol 121:531-559 (1985).
2. Ansar Ahmed S, Talal N. Sex steroids, sex steroid receptors and autoimmune disorders. In: Steroid Receptors and Disease: Cancer, Autoimmune, Bone, and Circulatory Disorders (Sheridan PJ, Blum K, Trachtenberg MC, eds). New York:Marcel Dekker, 1988;289-316.
3. Ansar Ahmed S, Talal N. Effect of Sex hormones on immune responses and autoimmune diseases: an update. In: A Decade of Autoimmunity (Shoenfeld Y, ed). Amsterdam:Elsevier, 1998;325-329.
4. Ansar Ahmed S, Talal N. Sex hormones and the immune system - Part 2: Animal data. Bailliere Clin Rheumatol 4:13-31 (1990).
5. Ansar Ahmed S, Talal N. Importance of sex hormones in lupus. In: Dubois' Lupus Erythematosus (Wallace DJ, Hahn BH, eds). Malvern, PA:Lea Fibiger, 1993;148-156.
6. Grossman CJ. Regulation of the immune system by sex steroids. Endocr Rev 5:435-454 (1984).
7. Lahita R. Sex hormones and the immune response - human studies. Bailliere Clin Rheumatol 4:1-12 (1990).
8. Olsen NJ, Kovacs WJ. Gonadal steroids and immunity. Endocr Rev 17:369-384 (1996).
9. Marselos M, Tomatis L. Diethylstilboestrol. I: Pharmacology, toxicology and carcinogenicity in humans. Eur J Cancer 28A:1182-1189 (1992).
10. Herbst AL, Ulfelder H, Poskanzer DC. Adenocarcinoma of the vagina: association of maternal stilbestrol therapy with tumor appearance in young women. N Engl J Med 284:878-881 (1971).
11. Marselos M, Tomatis L. Diethylstilboestrol. II: Pharmacology, toxicology and carcinogenicity in experimental animals. Eur J Cancer 29A:149-155 (1993).
12. DES Task Force Report. Washington, DC:U.S. Government Printing Office, 1978.
13. McMartin MC, Kenedy KE, Greenspan KA, Alam P, Greiner P, Yam J. Diethylstilbestrol: a review of its toxicity and use as a growth promotant in food-producing animals. J Environ Pathol Toxicol 1:279-313 (1978).
14. Shelby MD, Newbold RR, Tully DB, Chae K, Davis VL. Assessing environmental chemicals for estrogenicity using a combination of in vitro and in vivo assays. Environ Health Perspect 104:1296-1300 (1996).
15. Kavlock RJ, Daston GP, DeRosa C, Fenner-Crisp P, Gray E, Kaattari S, Lucier G, Luster M, Mac MJ, Maczka C, et al. Research needs for the risk assessment of health and environmental effects of endocrine disruptors: a report of the U.S. EPA-sponsored workshop. Environ Health Perspect 104:715-740 (1996).
16. Jacobson DL, Gange SJ, Rose NR, Graham NMH. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol 84:223-243 (1997).
17. Vollenhoven RFV, Engleman EG, McGuire JL. An open study of dehydroepiandrosterone in systemic lupus erythematosus. Arthritis Rheum 37:1305-1310 (1994).
18. Olsen N, Kovacs WJ. Case report: testosterone treatment of systemic lupus erythematosus in a patient with Klinefelter's syndrome. Am J Med Sci 310:158-160 (1995).
19. Newbold RR. Bullock BC, McLachlan JA. Uterine adenocarcinoma in mice following developmental treatment with estrogens: a model for hormonal carcinogenesis. Cancer Res 50:7677-7681 (1990).
20. Noller KL, Blair PB, O'Brien PC, Melton LJ III, Offord JR, Kauffman, RH, Colton T. Increased occurrence of autoimmune disease among women exposed in utero to diethylstilbestrol. Fertili Steril 49:1080-1082 (1988).
21. Wingard DL, Turiel J. Long-term effects of exposure to diethylstilbestrol. West J Med 149:551-554 (1988).
22. Baird DD, Wilcox AJ, Herbst AL. Self-reported allergy, infection and autoimmune diseases among men and women exposed in utero to diethylstilbestrol. J Clin Epidemiol 49:263-266 (1996).
23. 1 mice: a new model of lupus-like disease. J Exp Med 179: 1429-1435 (1994).
24. 1 mice. J Exp Med 147:1568 (1978).
25. 1 mice treated with the testosterone-blocking drug flutamide. J Lab Clin Med 124:401-407 (1994).
26. 1 mice. Unpublished abstract presented at the Workshop on Linking Environmental Agents and Autoimmune Diseases, 1-3 September 1998, Research Triangle Park, North Carolina.
27. Carlsten H, Tarkowski A, Holmdahl R, Nilsson LA. Oestrogen is a potent disease accelerator in SLE-prone MRL/lpr/lpr mice. Clin Exp Immunol 80:467-473 (1990).
28. Dayan M, Zinger H, Kalush F, Mor G, Amir-Zoltman Y, Kohen F, Stohger Z, Moses E. The beneficial affects of treatment with tamoxifen and anti-oestradiol antibody on experimental systemic lupus erythematosus are associated with cytokine modulations. Immunology 90:101-108 (1997).
29. Fitzpatrick F, Lepault F, Homo-Delarche F, Bach J-F, Dardenne M. Influence of castration, alone or combined with thymectomy, on the development of diabetes in nonobese diabetes mouse. Endocrinology 129:1382-1390 (1991).
30. Da Silva JAP, Larbre J-P, Seed MP, Cutolo M, Villaggio B, Scott D, Willoughby DA. Sex differences in inflammation induced cartilage damage in rodents. The influence of sex steroids. J Rheumatol 21:330-336 (1993).
31. Dalal M, Kim S, Voskhl RR. Testosterone therapy ameliorates experimental autoimmune encephalomyelitis and induces a T helper 2 bias in autoantiogen-specific T lymphocyte response. J Immunol 159:3-6 (1997).
32. Blair PB. Immunologic consequences of early exposure of experimental rodents to diethylstilbestrol and steroid hormones. In: Developmental Effects of Diethylstilbestrol (DES) in Pregnancy (Herbst AL, Bern HA, eds). New York:Thieme-Stralton, 1981;167-178.
33. Kalland T, Strand O, Forsberg J-G. Long term effects of neonatal estrogen treatment on mitogen responsiveness of mouse splenic lymphocytes. J Natl Cancer Inst 63:413-421 (1979).
34. Kalland T. Exposure of neonatal female mice to diethylstilbestrol persistently impairs NK activity through reduction of effector cells at the bone marrow level. Immunopharmacology 7:127-134 (1984).
35. Kato K, Chen Y, Nakane A, Tomonori M, Fujieda K, Kimura T, Yamamoto K. Suppression of delayed-type hypersensitivity in mice pretreated with diethylstilbestrol. J Leuk Biol 43:530-538 (1988).
36. Luster MI, Fate RE, McLachlan JA, Clark GC. Effect of in utero exposure to diethylstilbestrol on the immune response in mice. Toxicol Appl Pharmacol 47:279-285 (1979).
37. Ansar Ahmed S, Verthelyi D. Antibodies to cardiolipin in normal C57BL/6: induction by estrogen but not dihydrotestosterone. J Autoimmun 6:265-269 (1993).
38. Verthelyi D, Ansar Ahmed S. 17β-Estradiol, but not 5α-dihydrotestosterone, augments antibodies to double stranded deoxyribonucleic acid in non-autoimmune C57BL/6. Endocrinology 135:2615-2622 (1994).
39. Verthelyi D, Ansar Ahmed S. Characterization of estrogen-induced antibodies to cardiolipin in non autoimmune mice. J Autoimmun 10:115-125 (1997).
40. Ansar Ahmed S, Hissong BD, Donner KJ, Nordyke PG, Vaught T, Becker KM, Gogal RM, Walsh JE, Verthelyi DI. Immunological consequences of exposure to estrogens: aberrant spontaneous and induced lymphocyte activation [Abstract]. Am J Repr Immunol 40:281 (1998).
41. Donner KJ, Becker KM, Hissong BD, Ansar Ahmed S. Comparison of multiple assays for kinetic detection of apoptosis in thymocytes exposed to dexamethasone or diethylstilbestrol. Cytometry 35:1-11 (1999).
42. Staples EJ, Fiore NC, Frazier DE, Gasiewicz TA, Silverstone AE. Overexpression of the anti-apoptotic oncogen, bcl-2, in the thymus does not prevent thymic atrophy induced by estradiol or 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol Appl Pharmacol 151:200-210 (1998).
43. Gulino A, Screpanti I, Torrisi MR, Frati L. Estrogen receptor and estrogen sensitivity of fetal thymocytes are restricted to blast cells. Endocrinology 117:47-54 (1985).
44. Hissong BD, Donner K, Karpuzoglu-Sahin E, Ansar Ahmed S. Unpublished observations.
45. + T-lymphocyte activity in vivo and in vitro in β-microglobulin deficient mice. Immunology 86: 162-167 (1995).
46. Karpuzoglu-Sahin E, Yin Z, Ansar Ahmed S, Sriranganathan N. Long-term estrogen treatment alters cytokine gene and protein expression in normal mice [Abstract]. Exp Biol 99:A320 (1999).
47. Gilmore W, Weiner LP, Correale J. Effect of estradiol on cytokine secretion by proteolipid protein-specific T cell clones isolated from multiple sclerosis patients and normal control subjects. J Immunol 158:446-451 (1997).
48. Li ZG, Danis VA, Brooks PM. Effect of gonadal steroids on the production of IL-1 and IL-6 by blood mononuclear cells in vitro. Clin Exp Rheumatol 11:157-162 (1993).
49. Piccinni M-P, Giudizi M-G, Biagiotti R, Beloni L, Giannarini L, Sampognaro S, Parronchi P, Manetti R, Annunziato F, Livi C, et al. Progesterone favors the development of human T helper cells producing Th2-type cytokine and promotes both IL-4 production and membrane CD30 expression in established Th1 cell clones. J Immunol 155: 128-133 (1995).
50. Szekeres-Bartho J, Szekeres GY, Debre P, Autran B, Chaoaut G. Reactivity of lymphocytes to a progesterone receptor-specific monoclonal antibody. Cell Immunol 125:273-283 (1990).
51. Szekeres-Bartho J, Wegmann TG. A progesterone-dependent immunomodulatory protein alters the Th1/Th2 balance. J Reprod Immunol 31:81-95 (1996).
52. Okuyama R, Abo T, Seki S, Ohteki T, Sugiura K, Kusumi A, Kumagai K. Estrogen administration activates activates extrathymic T cell differentiation in the liver. J Exp Med 175:661-669 (1992).
53. Verthelyi D, Ansar Ahmed S. Estrogen increases the number of plasma cells and enhances their autoantibody production in non-autoimmune C57BL/6 mice. Cell Immunol 189: 125-134 (1998).
54. Jo T, Terada N, Saji F, Tanizawa O. Inhibitory effects of estrogen, progesterone, androgen and glucocorticoid on death of neonatal mouse uterine epithelial cells induced to proliferate by estrogen. J Steroid Biochem Mol Biol 46: 25-32 (1993).
55. Teixeira C, Reed JC, Pratt M. Estrogen promotes chemotherapeutic drug resistance by a mechanism involving Bcl-2 protooncogene expression in human breast cancer cells. Cancer Res 55:3902-3907 (1995).
56. Verthelyi D. Effects of Estrogen on the B-Cell Functions of Normal Mice. PhD Thesis. Blacksburg, VA:Virginia Polytechnic Institute and State University, 1996.
57. Verthelyi D, Ansar Ahmed S. Unpublished observations.
58. Hissong BD, Donner KJ, Vaught T, Nordyke P, Ansar Ahmed S. Unpublished observations.
59. Kong L, Ogawa N, Nakabayashi T, Liu GT, D-Souza E, McGuff HS, Guerrero D, Talal N, Dang H, Fas and Fas ligand expression in the salivary glands of patients with primary Sjögren's syndrome. Arthritis Rheum 40:87-97 (1997).
60. Sullivan DA Hormonal influence on the secretory immune system of the eye. In: The Neuroendcorine-Immune Network (Frier S, ed). Boca Raton, FL:CRC Press, 1990;200-237.